CSX Shares CleanSpace Holdings Limited
ASX · ASXLast in our picks 2026-09-30 — not in the current list; analysis below is from that screen
High-quality defensive biotech with institutional support offers lower-risk compounder exposure.
Future value: $0.90 (+100.00%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Stable institutional ownership, but near-term upside appears limited.
- ▸Above 50-day MA (+10.81%)
- ▸~100% upside to price target
Is CSX a buy right now?
Trend: CSX is trading above the 50-day average (+11.63%), RSI 35 — neutral momentum, with a 3-month return of +18.52%.
Valuation & quality: CleanSpace Holdings Limited trades on forward P/E 13.5, price-to-book 2.06; fundamentals show net margin -6.3%, return on equity -6.6%, revenue growth -7.9% year on year.
Analyst consensus: 1 analysts have a mean 12-month price target of A$0.90 (+87.5% vs the last close; range A$0.90 – A$0.90), consensus rating “none”.
Our screen: BUY (score 2) — High-quality defensive biotech with institutional support offers lower-risk compounder exposure.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -19.30% | -4.30% | -13.60% | +5.30% | +2.50% | -2.40% | +12.50% | +6.70% |
Fundamentals
Analyst price target
Technical signals
About CleanSpace Holdings Limited
CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally.
Sector: Healthcare · Industry: Medical Devices · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.